Home | Clinical Trials


Therapeutic Areas: Oncology | Pediatrics/Neonatology | Neurology

Neuroblastoma Clinical Trials


A listing of Neuroblastoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Arizona

Phoenix : Phoenix Children's Hospital

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

Phoenix : Phoenix Children'S Hospital

Patients are needed to participate in a clinical research study of Cyclophosphamide, Topotecan, and Bevacizumab to evaluate Neuroblastoma or Sarcoma

California

San Diego : Rady Children's Hospital

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

San Diego : Rady Children's Hospital

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

Colorado

Denver : University of Colorado Health Sciences Center and The Children's Hospital

Patients are needed to participate in a clinical research study of Cyclophosphamide, Topotecan, and Bevacizumab to evaluate Neuroblastoma or Sarcoma

Connecticut

Hartford : Connecticut Children's Hospital

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Hartford : Connecticut Children's Hospital

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

Florida

Orlando : Arnold Palmer Hospital for Children- MD Anderson

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Orlando : Arnold Palmer Hospital for Children- MD Anderson

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

Georgia

Savannah : Memorial University Medical Center

ACNS0821:Temozolomide With Irinotecan Versus Temozolomide, Irinotecan Plus Bevacizumab (NSC# 704865, BB-IND# 7921) for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, A COG Randomized Phase II Screening Trial

Hawaii

Honolulu : Kapiolani Medical Center for Women and Children

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Honolulu : Kapiolani Medical Center for Women and Children

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

Maryland

Baltimore : GSK Investigational Site

A clinical trial to evaluate treatments using GSK525762 for patients with Carcinoma, Midline

Massachusetts

Boston : GSK Investigational Site

A clinical trial to evaluate treatments using GSK525762 for patients with Carcinoma, Midline

Boston : Tufts Medical Center

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

Michigan

Grand Rapids : Helen DeVos Children's Hospital

A clinical research study of DFMO and Bortezomib for the treatment of Neuroblastoma- Relapsed and Refractory

Grand Rapids : Helen DeVos Children's Hospital

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Grand Rapids : Helen DeVos Children's Hospital

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

Minnesota

Minneapolis : Children's Hospital and Clinics on Minnesota

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

Missouri

Kansas City : Children's Mercy Hospitals and Clinics

A clinical research study of DFMO and Bortezomib for the treatment of Neuroblastoma- Relapsed and Refractory

Kansas City : Children's Mercy Hospitals and Clinics

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Kansas City : Children's Mercy Hospitals and Clinics

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

Kansas City : Children's Mercy Hospital & Clinics

Patients are needed to participate in a clinical research study of Cyclophosphamide, Topotecan, and Bevacizumab to evaluate Neuroblastoma or Sarcoma

St. Louis : Cardinal Glennon Children's Medical Center

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

St. Louis : Cardinal Glennon Children's Medical Center

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

New York

Bronx : Children's Hospital at Montefiore

A clinical trial seeking patients for a research study of Aromatherapy Scented Wand and Placebo wand

New York : Memorial Sloan-Kettering Cancer Center

Patients are needed to participate in a clinical research study of Cyclophosphamide, Topotecan, and Bevacizumab to evaluate Neuroblastoma or Sarcoma

North Carolina

Charlotte : Levine Children's Hospital

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Charlotte : Levine Children's Hospital

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

Oklahoma

Oklahoma City :

Patients are needed to participate in a clinical research study of MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide for Pediatric Solid Tumors

Pennsylvania

Hershey : Penn State Milton S. Hershey Medical Center and Children's Hospital

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Hershey : Penn State Milton S. Hershey Medical Center and Children's Hospital

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

Philadelphia : GSK Investigational Site

A clinical trial to evaluate treatments using GSK525762 for patients with Carcinoma, Midline

Pittsburgh : Children's Hospital of Pittsburgh

A clinical trial seeking patients for a research study for the treatment of Neuroblastoma or Opsoclonus-Myoclonus

South Carolina

Charleston : Medical University of South Carolina

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Charleston : Medical University of South Carolina

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

Tennessee

Memphis : St. Jude Children's Research Hospital

A clinical trial to evaluate treatments for patients with Pediatric Solid Tumors

Nashville : Vanderbilt-Ingram Cancer Center

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

Texas

Austin : Dell Children's Blood and Cancer Center

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

Dallas : Children's Medical Center

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Dallas : Children's Medical Center

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

Dallas :

Patients are needed to participate in a clinical research study of MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide for Pediatric Solid Tumors

Houston : GSK Investigational Site

A clinical trial to evaluate treatments using GSK525762 for patients with Carcinoma, Midline

Houston : Texas Children's Cancer and Hematology Centers

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Houston : Texas Children's Cancer and Hematology Centers

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

Utah

Salt Lake City : Primary Children's Hospital

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Salt Lake City : Primary Children's Hospital

Patients are needed to participate in a clinical research study evaluating DFMO for the treatment of Neuroblastoma

Wisconsin

Milwaukee :

Patients are needed to participate in a clinical research study of MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide for Pediatric Solid Tumors

Canada

Calgary : Alberta Children'S Hospital

Patients are needed to participate in a clinical research study of Cyclophosphamide, Topotecan, and Bevacizumab to evaluate Neuroblastoma or Sarcoma

Denmark

Copenhagen : University Hospital Rigshospitalet

Patients are needed to participate in a clinical research study for the treatment of Neuroblastoma

France

Toulouse : Hopital des Enfants

Patients are needed to participate in a clinical research study for the treatment of Neuroblastoma

Ireland

Dublin : Our Ladys Children's Hospital Dublin

Patients are needed to participate in a clinical research study for the treatment of Neuroblastoma

Spain

Valencia : Instituto de Investigacion Sanitaria

Patients are needed to participate in a clinical research study for the treatment of Neuroblastoma

United Kingdom

Sutton : The Royal Marsden NHS Foundation Trust and Institute of Cancer Research

Patients are needed to participate in a clinical research study for the treatment of Neuroblastoma